Amid the ongoing COVID-19 pandemic, the spotlight has turned to N-acetylglucosamine, a compound being studied for its potential in treating COVID-19 patients. Alongside established treatments like remdesivir, N-acetylglucosamine shows promise in combating the virus, creating revenue opportunities for manufacturers in the acetylglucosamine market. Beyond its role in healthcare, acetylglucosamine...